American journal of physical medicine & rehabilitation · 2026
Complexity, Multi-Morbidity, Polypharmacy and Disability in People With Multiple Sclerosis Seen by A Canadian Specialist in Physical Medicine and Rehabilitation. A Retrospective Chart Review.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Scandiffio Jillian, Sureshkumar Ashvene, Schmitt Brenna, Speranza Mikayla, Langer Laura, Donkers Sarah, Oh Jiwon, Munce Sarah, Bayley Mark, Bruno Tania, Simpson Robert
Аннотация
OBJECTIVE: To describe the characteristics and needs of people with multiple sclerosis (PwMS) seen by specialist physical medicine and rehabilitation (PM&R).
DESIGN: A retrospective chart review of all PwMS seen by physiatry (n=477) at the largest Canadian MS clinic between December 2021 and December 2023 was conducted. Demographic characteristics, symptoms, comorbidities, medications, health service use, MRI findings, and physical examination findings were collected. Log-binomial regressions were conducted to examine the association between symptoms and health service.
RESULTS: Participants had a high number of symptoms (M=6.55, SD=2.22), with most reporting fatigue (78.6%), spasticity (78.2%), pain (74.4%), bladder dysfunction (75.7%), and emotional symptoms (59.5%). Cognitive (PR=1.23, 95% CI=1.12-1.36), emotional (PR=1.13, 95% CI 1.02-1.26), and swallowing (PR=1.14, 95% CI=1.02-1.28) symptoms were significantly associated with multiple health services use. Comorbidity count was high (Mdn=3, IQR=1-4) with the most common being depression (23.7%), hypertension (22.2%), anxiety (13.2%), hyperlipidemia (13.2%), and osteoporosis (10.9%). PwMS had high levels of polypharmacy, with an average of 7.3 (SD=4.1) medications used.
CONCLUSION: PwMS seen by specialty PM&R are clinically complex, with high symptom and comorbidity burden, polypharmacy, and disability. Physiatrists working with PwMS should be trained to manage common symptoms, comorbidities, and high levels of polypharmacy for optimal care.
DESIGN: A retrospective chart review of all PwMS seen by physiatry (n=477) at the largest Canadian MS clinic between December 2021 and December 2023 was conducted. Demographic characteristics, symptoms, comorbidities, medications, health service use, MRI findings, and physical examination findings were collected. Log-binomial regressions were conducted to examine the association between symptoms and health service.
RESULTS: Participants had a high number of symptoms (M=6.55, SD=2.22), with most reporting fatigue (78.6%), spasticity (78.2%), pain (74.4%), bladder dysfunction (75.7%), and emotional symptoms (59.5%). Cognitive (PR=1.23, 95% CI=1.12-1.36), emotional (PR=1.13, 95% CI 1.02-1.26), and swallowing (PR=1.14, 95% CI=1.02-1.28) symptoms were significantly associated with multiple health services use. Comorbidity count was high (Mdn=3, IQR=1-4) with the most common being depression (23.7%), hypertension (22.2%), anxiety (13.2%), hyperlipidemia (13.2%), and osteoporosis (10.9%). PwMS had high levels of polypharmacy, with an average of 7.3 (SD=4.1) medications used.
CONCLUSION: PwMS seen by specialty PM&R are clinically complex, with high symptom and comorbidity burden, polypharmacy, and disability. Physiatrists working with PwMS should be trained to manage common symptoms, comorbidities, and high levels of polypharmacy for optimal care.